These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5960916)

  • 21. [Evaluation of the specificity of anti-proliferative drugs. Comparison of nitrogen mustard, triethylene melamine and cyclophosphamide].
    SCALTRINI GC; TOGNELLA S; CONIGLIARO S; GRIFONI V
    Haematol Lat; 1961; 4():411-22. PubMed ID: 14497771
    [No Abstract]   [Full Text] [Related]  

  • 22. Potential carcinolytic agents. V. Enamine mustards.
    Papanastassiou ZB; Bruni RJ; White E
    J Med Chem; 1967 Jul; 10(4):701-6. PubMed ID: 6037064
    [No Abstract]   [Full Text] [Related]  

  • 23. Early clinical trials with anticancer agents; phase I and phase II studies. A. Dosage schedules and routes of administration.
    SHNIDER BI
    Cancer Chemother Rep; 1962 Feb; 16():61-7. PubMed ID: 13912202
    [No Abstract]   [Full Text] [Related]  

  • 24. N-(2-chloroethyl)-DL-aspartic acid and some related amino acids.
    Arnaiz JL; Falszpan J
    J Med Chem; 1966 Nov; 9(6):978-9. PubMed ID: 5972076
    [No Abstract]   [Full Text] [Related]  

  • 25. Potential anticancer agents. II. Urethan-type nitrogen mustards of some natural sex hormones.
    Niculescu-Duvăz I; Cambanis A; Tărnăuceanu E
    J Med Chem; 1967 Mar; 10(2):172-4. PubMed ID: 6034059
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of nitrogen mustard on the liver, administered by the isolated perfusion technique.
    CHUNG WB; FORWARD AD; BROWN DA
    Surg Forum; 1961; 12():127-8. PubMed ID: 13879408
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the resistance of tumor cells to chemotherapeutic agents].
    GATI E
    Z Krebsforsch; 1960; 63():372-7. PubMed ID: 13826850
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives.
    Singh RK; Kumar S; Prasad DN; Bhardwaj TR
    Eur J Med Chem; 2018 May; 151():401-433. PubMed ID: 29649739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prophylactic treatment of malignant disease with nitrogen mustard and triethylenethiophosphoramide (thio-TEPA).
    MCDONALD GO; LIVINGSTON C; BOYLES CF; COLE WH
    Ann Surg; 1957 May; 145(5):624-9. PubMed ID: 13425269
    [No Abstract]   [Full Text] [Related]  

  • 30. Antitumor and mutagenic properties of a variety of heterocyclic nitrogen and sulfur mustards.
    Creech HJ; Preston RK; Peck RM; O'Connell AP
    J Med Chem; 1972 Jul; 15(7):739-46. PubMed ID: 4557857
    [No Abstract]   [Full Text] [Related]  

  • 31. Structure-activity relationship of aniline mustards acting against B-16 melanoma in mice.
    Panthananickal A; Hansch C; Leo A
    J Med Chem; 1979 Oct; 22(10):1267-9. PubMed ID: 513075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential anticancer agents. XX. 1. Steric fit analysis in aromatic nitrogen mustards area.
    Bădilescu II; Crăescu T; Niculescu-Duvăz I; Simon Z
    Neoplasma; 1980; 27(3):261-9. PubMed ID: 7453846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies in the pharmacodynamics of mechlorethamine and AB 100.
    AUSMAN RK; CREVAR GE; HAGEDORN H; BARDOS TJ; AMBRUS JL
    JAMA; 1961 Nov; 178():735-8. PubMed ID: 13863314
    [No Abstract]   [Full Text] [Related]  

  • 34. N4-(2-bromoethyl)-N4-ethylsulfanilamide, a monofunctional nitrogen mustard with antitumor action.
    Hebborn P; Triggle DJ
    J Med Chem; 1965 Jul; 8(4):541-2. PubMed ID: 5899085
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of chemotherapy in ovarian and cervical cancer by tissue culture methods.
    MOORE JG; BRANDKAMP WW; BURNES WL
    Am J Obstet Gynecol; 1959 Apr; 77(4):780-94. PubMed ID: 13637141
    [No Abstract]   [Full Text] [Related]  

  • 36. Interaction with heparin of deoxyribonucleoprotein complex damaged in vivo by nitrogen mustards.
    Matyásová J; Skalka M
    Biochem Pharmacol; 1968 May; 17(5):830-3. PubMed ID: 5649897
    [No Abstract]   [Full Text] [Related]  

  • 37. Attempt to establish a correlation between the alkylation ability and antitumor activity of some bis(2-chloroethyl)aminoethyl esters of carboxylic acids.
    Manolov I; Golovinsky EV
    Pharmazie; 1988 Mar; 43(3):218-9. PubMed ID: 3380873
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the antineoplastic properties of N,N-bis-(beta-chloroethyl)-lysine derivatives ("lysepsin")].
    LARIONOV LF; SPASSKAIA IG
    Vopr Onkol; 1961; 7(11)():75-9. PubMed ID: 14462423
    [No Abstract]   [Full Text] [Related]  

  • 39. Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. XV. Determination of minimum effective dose of nitromin and other compounds by in vitro tests.
    ISHIDATE M; SAKURAI Y; YOSHIDA T; SATOH H
    Gan; 1956 Dec; 47(3-4):382-4. PubMed ID: 13415048
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. XIV. Inhibiting effect of nitromin upon small number of Yoshida sarcoma cells. 3].
    ISHIDATE M; SAKURAI Y; YOSHIDA T; SATOH H
    Gan; 1956 Dec; 47(3-4):380-2. PubMed ID: 13415047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.